Patient preference study of once-monthly ibandronate versus once-weekly alendronate

被引：0

作者：

Emkey, R

Binkley, N

Seidman, L

Rosen, C

机构：

[1] Reading Hosp, Reading, PA USA

[2] Univ Wisconsin, Madison, WI 53706 USA

[3] Philadelphia Womens Res, Philadelphia, PA USA

[4] St Joseph Hosp, Bangor, ME 04401 USA

来源：

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2005年 / 12卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：797 / 797

页数：1

共 50 条

[1] Balto I: Patient preference and convenience study of once-monthly ibandronate versus once-weekly alendronate for the treatment of osteoporosis.
Emkey, R
Binkley, N
Seidman, L
Rosen, C
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S296 - S296
[2] Once-monthly ibandronate and once-weekly alendronate: Preference results from the BALTO I and II studies
Emkey, R
Kivitz, A
Koltun, W
Leslie, B
JOURNAL OF WOMENS HEALTH, 2006, 15 (04) : 469 - 469
[3] BALTO I: Women treated for osteoporosis rate preference and convenience for once-monthly ibandronate versus once-weekly alendronate.
Emkey, R
Binkley, N
Seidman, L
Rosen, C
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S416 - S416
[4] Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study
Cooper, A.
Drake, J.
Brankin, E.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) : 896 - 905
[5] Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)
Emkey, R
Koltun, W
Beusterien, K
Seidman, L
Kivitz, A
Devas, V
Masanauskaite, D
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) : 1895 - 1903
[6] Patient preference for once-monthly oral ibandronate and weekly oral alendronate in postmenopausal osteoporosis: The BALTO II study
不详
CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S127 - S128
[7] The BALTO II study: Patient preference for once-monthly oral ibandronate and weekly oral alendronate in postmenopausal osteoporosis
Minne, H.
Bourgeois, P.
Devas, V.
Masanauskaite, D.
Minic, B.
Licata, A.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 423 - 423
[8] Improved patient satisfaction with once-monthly ibandronate in women previously receiving once-weekly alendronate or risedronate for postmenopausal osteoporosis or osteopenia.
Bonnick, S. L.
Tanner, S. B.
Martens, M.
Civitelli, R.
Kornowski, A.
Silverman, S.
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S285 - S285
[9] Patient preference for once-monthly lbandronate compared with weekly alendronate in postmenopausal osteoporosis
Seidman, Larry S.
Kornowski, Anne
Devas, Vipul
Masanauskaite, Daiva
Emkey, Ron
OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 24S - 25S
[10] More patients prefer once-monthly ibandronate to Once-weekly alendronate: Results of clinical studies BALTO I and BALTO II
Kroll, Robin
Emkey, Ronald
Masanauskaite, Daiva
Devas, Vipul
Licata, Angelo
Weissman, Peter
Binkley, Neil
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (06): : 1004 - 1004

← 1 2 3 4 5 →